Lapic et al. [53] analyzed the role of various missense variants of coagulation factors II, V, and XIII, as well as further proteins supposed to modulate thrombotic risk in COVID-19, including platelet integrin receptors, the endothelial nitric oxide synthase, and methylene tetrahydrofolate reductase. This evidence concerns the gene F2 and COVID-19.